| Megan E Strand, ICMHC | |
|
1760 N Main St Ste 105, Cedar City, UT 84721-7807 | |
| (435) 688-1111 | |
| (435) 688-8488 |
| Full Name | Megan E Strand |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1760 N Main St Ste 105, Cedar City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093390528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan E Strand, ICMHC 1173 S 250 W Ste 208, St George, UT 84770-6747 Ph: (435) 688-1111 | Megan E Strand, ICMHC 1760 N Main St Ste 105, Cedar City, UT 84721-7807 Ph: (435) 688-1111 |
News Archive
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of approximately 7.14 million shares of its common stock at a price of $4.90 per share which will result in gross proceeds of $35 million. Net proceeds to the company, after underwriting discounts and commissions and expenses, will be approximately $32.8 million.
HIV infection rates among gay men and other men who have sex with men (MSM) in "some African countries are 10 times that of the general male population, and stigma, poor access to treatment or testing are to blame," according to a Lancet study published online on Monday, AFP/China Post reports.
The U.S. Food and Drug Administration recently approved the first new drug to fight tuberculosis (TB) in more than 40 years, but treatment still takes six months, 200 pills and leaves 40 percent of patients uncured. Thus, new targets are needed. Today in ACS Central Science, researchers report they have identified one such target - a gene that allows the disease to camp out in human immune cells, and is thus essential for the organism's proliferation.
Wireless Health 2013, presented by the Wireless-Life Sciences Alliance, invites the most advanced research from health, biomedical, engineering and computer science disciplines to encourage the development of widely usable mobile health solutions.
Teva Pharmaceutical Industries Ltd. today announced preclinical data demonstrating reparative and neuroprotective effects of treatment with COPAXONE (glatiramer acetate injection) in experimental autoimmune encephalomyelitis (EAE) models.
› Verified 9 days ago
Brent J. Lambeth, CMHC Counselor Medicare: Medicare Enrolled Practice Location: 465 W 1600 N, Cedar City, UT 84721 Phone: 435-586-2500 | |
Spencer Kohler, ACMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2069 N Main St Ste 101, Cedar City, UT 84721 Phone: 435-267-4212 | |
David Coan I, CSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 17 N 1150 W, Cedar City, UT 84720 Phone: 435-559-1067 | |
Colten Pendleton, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1870 N Main St Ste 102, Cedar City, UT 84721 Phone: 801-255-5131 | |
Chris Bagby, CMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 440 N Paiute Dr, Cedar City, UT 84721 Phone: 435-586-6111 | |
Cody Lamb, Counselor Medicare: Not Enrolled in Medicare Practice Location: 6484 N 2300 W, Cedar City, UT 84721 Phone: 435-867-4876 Fax: 435-867-4893 | |
Anna Kelly, Counselor Medicare: Not Enrolled in Medicare Practice Location: 91 North 1850 West, Cedar City, UT 84720 Phone: 435-865-6481 |